Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management

EA Gorman, CM O'Kane, DF McAuley - The Lancet, 2022 - thelancet.com
Acute respiratory distress syndrome (ARDS) is characterised by acute hypoxaemic
respiratory failure with bilateral infiltrates on chest imaging, which is not fully explained by …

[HTML][HTML] Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind …

CT Bramante, JB Buse, DM Liebovitz… - The Lancet Infectious …, 2023 - thelancet.com
Summary Background Post-COVID-19 condition (also known as long COVID) is an
emerging chronic illness potentially affecting millions of people. We aimed to evaluate …

Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up

CT Bramante, JB Buse, D Liebovitz, J Nicklas… - medRxiv, 2022 - pmc.ncbi.nlm.nih.gov
Background Long Covid is an emerging chronic illness potentially affecting millions,
sometimes preventing the ability to work or participate in normal daily activities. COVID-OUT …

Post COVID and Apheresis–Where are we Standing?

C Steenblock, R Walther, S Tselmin… - Hormone and …, 2022 - thieme-connect.com
A continual increase in cases of Long/Post COVID constitutes a medical and socioeconomic
challenge to health systems around the globe. While the true extent of this problem cannot …

Long COVID: the next public health crisis is already on its way

C Yang, SJ Tebbutt - The Lancet Regional Health–Europe, 2023 - thelancet.com
Conservative estimates suggest that over 200 million SARS-CoV-2 infected individuals
worldwide will develop persistent symptoms of COVID-19, also referred to as" long …

Omicron variants of SARS-CoV-2 and long COVID

C Yang, H Zhao, CP Shannon, SJ Tebbutt - Frontiers in Immunology, 2022 - frontiersin.org
Understanding the epidemiology of long COVID and emerging variants has significant
public-health implications as physical interventions and restrictions that help limit viral …

Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections

SJ Hurwitz, R De, JC LeCher, JA Downs-Bowen… - Viruses, 2024 - mdpi.com
Most repurposed drugs have proved ineffective for treating COVID-19. We evaluated median
effective and toxic concentrations (EC50, CC50) of 49 drugs, mostly from previous clinical …

Investigation into the restoration of TRPM3 ion channel activity in post-COVID-19 condition: a potential pharmacotherapeutic target

EM Sasso, K Muraki, N Eaton-Fitch, P Smith… - Frontiers in …, 2024 - frontiersin.org
Introduction Recently, we reported that post COVID-19 condition patients also have
Transient Receptor Potential Melastatin 3 (TRPM3) ion channel dysfunction, a potential …

Clinical and functional assessment of SARS-CoV-2 sequelae among young marines–a panel study

CK Porter, CG Beckett, E Cooper, L White… - The Lancet Regional …, 2024 - thelancet.com
Summary Background Long-term SARS-CoV-2 adverse health outcomes are of significant
concern, especially among young adults with the potential for the greatest long-term …